AEON Biopharma Reports Equity Inducement Awards Under NYSE American Section 711
IRVINE, CA — December 19, 2025 — AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical company focused on developing ABP-450 (prabotulinumtoxinA) ...
